跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,989 条关于
“HTT-PMS1”
全部
1,989
临床试验
1,443
药物
387
机构
14
资讯
145
10个月前
ReviR Therapeutics Secures $4.6M CIRM Grant for Dual-Target Huntington's Disease Therapy
2年前
Skyhawk's SKY-0515 Shows Promise in Huntington's Disease with 72% HTT mRNA Reduction
去年
Skyhawk Therapeutics Initiates Phase 2/3 Trial of SKY-0515 for Huntington's Disease
去年
Merck KGaA Partners with Skyhawk Therapeutics in $2 Billion RNA Splicing Collaboration for Neurological Disorders
3个月前
Huntington's Disease Market Poised for 14% CAGR Growth Through 2036 as Disease-Modifying Therapies Advance
7个月前
Skyhawk Therapeutics Reports Promising Nine-Month Data for Huntington's Disease Drug SKY-0515
8个月前
Oral HTT-Lowering Drug Branaplam Shows Promise but Halted Due to Peripheral Neuropathy in Phase 2 Huntington's Disease Trial
去年
Alnylam's ALN-HTT02: First Patient Dosed in Phase 1 Huntington's Disease Trial
7个月前
RNA-Targeting Small Molecules Emerge as New Frontier in Drug Discovery with Major Pharma Partnerships
去年
Vico Therapeutics' VO659 Shows Promise in Huntington's Disease and Spinocerebellar Ataxias
第 1 页,共 15 页
上一页
下一页